Tomohiro Sakamoto

Efficacy of Selpercatinib in <i>RET</i> Fusion–Positive Non–Small-Cell Lung Cancer

Alexander Drilon, Geoffrey R. Oxnard, Daniel Shao-Weng Tan et al. · New England Journal of Medicine · 2020 · 810 citations · Full text

Comparison of the risk factors for coronary artery spasm with those for organic stenosis in a Japanese population: role of cigarette smoking

Kyoji Takaoka, Michihiro Yoshimura, Hisao Ogawa et al. · International Journal of Cardiology · 2000 · 115 citations

Tobacco Control, Cardiovascular Epidemiology, Health Policy +13

PL02.08 Registrational Results of LIBRETTO-001: A Phase 1/2 Trial of LOXO-292 in Patients with RET Fusion-Positive Lung Cancers

Alexander Drilon, Geoffrey R. Oxnard, Lori J. Wirth et al. · Journal of Thoracic Oncology · 2019 · 80 citations · Full text

Phase 1/2, Pl02.08 Registrational Results, Medicine +8

Trastuzumab emtansine for patients with non–small cell lung cancer positive for human epidermal growth factor receptor 2 exon-20 insertion mutations

Eiji Iwama, Yoshitaka Zenke, Shunichi Sugawara et al. · European Journal of Cancer · 2021 · 72 citations

Cell Lung Cancer, Medicine, Cancer Growth +9

First-Line Osimertinib for Previously Untreated Patients With NSCLC and Uncommon <i>EGFR</i> Mutations

Yusuke Okuma, Kaoru Kubota, Mototsugu Shimokawa et al. · JAMA Oncology · 2023 · 67 citations · Full text